Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol propionate for inflammation and pain after cataract surgery
NCT04246801Phase 3Completed
- Sponsor
- Laboratorios Salvat
- Start
- Jun 2020
- Primary completion
- May 2021
- Modality
- Nanoparticles, Implantable Devices, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 3 trial of GPN00833 in post-operative inflammation, postoperative pain, sponsored by Laboratorios Salvat. Started Jun 2020; status: completed.
02
Drugs
GPN00833
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT04246801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04246801.